{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:36Z","timestamp":1786998456507,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ymgmr.2024.101105","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T13:07:56Z","timestamp":1718629676000},"page":"101105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tocilizumab effectively reduces flares of hyperimmunoglobulin D syndrome in children: Three cases in China"],"prefix":"10.1016","volume":"40","author":[{"given":"Chenxi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huasong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ymgmr.2024.101105_bb0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1542\/peds.111.2.258","article-title":"Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum","volume":"111","author":"Prietsch","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2024.101105_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-1-13","article-title":"Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome","volume":"1","author":"Haas","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.ymgmr.2024.101105_bb0015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/annrheumdis-2021-221801","volume":"81","author":"Romano","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101105_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.RHU.0000442576.41537.de","article-title":"Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome","volume":"20","author":"Shendi","year":"2014","journal-title":"J. Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.ymgmr.2024.101105_bb0025","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"ter Haar","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101105_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12969-022-00716-4","article-title":"The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency","volume":"20","author":"Jeyaratnam","year":"2022","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101105_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13604","article-title":"Mevalonic aciduria: does stem cell transplant fully cure disease?","volume":"24","author":"Szymanski","year":"2020","journal-title":"Pediatr. Transplant."},{"issue":"6","key":"10.1016\/j.ymgmr.2024.101105_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.ymgmr.2024.101105_bb0050","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00431-015-2505-9","article-title":"Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience","volume":"174","author":"Kostjukovits","year":"2015","journal-title":"Eur. J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgmr.2024.101105_bb0055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-135-5-200109040-00010","article-title":"Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyperigd and periodic fever syndrome: its application as a diagnostic tool","volume":"135","author":"Simon","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.ymgmr.2024.101105_bb0060","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/art.39763","article-title":"The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever registry","volume":"68","author":"Ter Haar","year":"2016","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.ymgmr.2024.101105_bb0065","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003027","article-title":"Observational study of a French and Belgian multicenter cohort of 23 patients diagnosed in adulthood with mevalonate kinase deficiency","volume":"95","author":"Durel","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101105_bb0070","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2010-3639","article-title":"Mevalonate kinase deficiency: a survey of 50 patients","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101105_bb0075","first-page":"413","volume":"39","author":"Wang","year":"2022","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101105_bb0080","first-page":"62","article-title":"Mevalonic aciduria:one case report and literature review","volume":"27","author":"Li","year":"2012","journal-title":"Chin. J. Pract. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgmr.2024.101105_bb0085","first-page":"373","article-title":"Hyper-IgD and periodic fever syndrome\u202f:a case report and literature review","volume":"11","author":"Hou","year":"2016","journal-title":"Chin. J. Evid. Based Pediatr."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101105_bb0090","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group[J]","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.ymgmr.2024.101105_bb0095","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1002\/art.21381","article-title":"Pseudodominant inheritance of the hyperimmunoglobulinemia D with periodic fever syndrome in a mother and her two monozygotic twins","volume":"52","author":"Hospach","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101105_bb0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ejhg.5200595","article-title":"Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome [published correction appears in Eur J Hum Genet 2001 Aug;9(8):651]","volume":"9","author":"Houten","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101105_bb0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","article-title":"Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome","volume":"9","author":"Cuisset","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101105_bb0110","first-page":"2931","article-title":"Successful application of next-generation sequencing for prenatal diagnosis in a pedigree with chronic granulomatosis disease","volume":"17","author":"Peng","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101105_bb0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome[J]","volume":"22","author":"Houten","year":"1999","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101105_bb0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12969-023-00887-8","article-title":"A case of neonatal sweet syndrome associated with mevalonate kinase deficiency","volume":"21","author":"Irwin","year":"2023","journal-title":"Pediatr. Rheumatol. Online J."},{"issue":"19","key":"10.1016\/j.ymgmr.2024.101105_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160929","article-title":"Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency","volume":"132","author":"Munoz","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgmr.2024.101105_bb0130","article-title":"Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome [published online ahead of print, 2023 Aug 14]","author":"Ozdemir Isik","year":"2023","journal-title":"Int. J. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101105_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001227","article-title":"Systematic literature review of efficacy\/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumor necrosis factor receptor-associated periodic syndrome","volume":"6","author":"Kuemmerle-Deschner","year":"2020","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101105_bb0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-199405000-00002","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group","volume":"73","author":"Drenth","year":"1994","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101105_bb0145","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/mr\/roac041","article-title":"Real-world safety and effectiveness of canakinumab in patients with tumor necrosis factor receptor-associated periodic syndrome or hyperimmunoglobulinaemia D syndrome: interim results from postmarketing surveillance in Japan","volume":"33","author":"Hosono","year":"2023","journal-title":"Mod. Rheumatol."},{"issue":"5","key":"10.1016\/j.ymgmr.2024.101105_bb0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.55563\/clinexprheumatol\/e92f7o","article-title":"Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial","volume":"39 Suppl 132","author":"Lachmann","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.ymgmr.2024.101105_bb0155","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/rheumatology\/keab696","article-title":"Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomized phase 3 CLUSTER trial","volume":"61","author":"Jeyaratnam","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.ymgmr.2024.101105_bb0160","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/ced\/llad003","article-title":"Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab","volume":"48","author":"L\u00f3pez Sanz","year":"2023","journal-title":"Clin. Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101105_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003890","article-title":"Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry","volume":"10","author":"Kuemmerle-Deschner","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.ymgmr.2024.101105_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","article-title":"Interleukin-6: from basic science to medicine-40 years in immunology","volume":"23","author":"Kishimoto","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymgmr.2024.101105_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/CMAMD.S7371","article-title":"Safety and efficacy of tocilizumab for the treatment of rheumatoid arthritis","volume":"5","author":"Ogata","year":"2012","journal-title":"Clin. Med. Insights Arthritis. Musculoskelet Disord."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101105_bb0180","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/14397595.2018.1546357","article-title":"IL-6 inhibitor for the treatment of rheumatoid arthritis: a mprehensive review","volume":"29","author":"Ogata","year":"2019","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.ymgmr.2024.101105_bb0185","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s10875-020-00836-0","article-title":"Spontaneous gastrointestinal perforations in STAT3-deficient hyper-IgE syndrome","volume":"40","author":"Bhattacharya","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ymgmr.2024.101105_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.782780","article-title":"Case report: Mevalonic aciduria complicated by acute myeloid leukemia after hematopoietic stem cell transplantation","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Immunol."},{"issue":"26","key":"10.1016\/j.ymgmr.2024.101105_bb0195","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1056\/NEJMoa070715","article-title":"Allogeneic bone marrow transplantation in mevalonic aciduria","volume":"356","author":"Neven","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101105_bb0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/CDLI.7.2.131-140.2000","article-title":"Immunoglobulin D: properties, measurement, and clinical relevance","volume":"7","author":"Vladutiu","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T15:35:31Z","timestamp":1723908931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426924000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":39,"alternative-id":["S2214426924000582"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101105","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tocilizumab effectively reduces flares of hyperimmunoglobulin D syndrome in children: Three cases in China","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101105"}}